CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, announced today that it will be presenting at the Cold Spring Harbor Laboratory Molecular Genetics of Aging meeting. Jill Milne, Ph.D., Senior Director of Biology at Sirtris, will present “SIRT1 Activation: A Novel Mechanism for Treating Age-Related Diseases” and discuss the Company’s strategy for discovering and developing first in class therapeutics that modulate sirtuins, a recently discovered family of enzymes that promote healthy cellular function to treat diseases of aging, such as diabetes and neurological diseases.
